Second Harrington Prize Awarded to Oncologist Douglas Lowy for Work on HPV Vaccine
2011 Sabin Gold Medal Award Winner, Douglas Lowy, is awarded the Harrington Prize for his work on the HPV vaccine.
"A National Cancer Institute researcher and oncologist credited with the discovery that made a human papilloma virus (HPV) vaccine possible is the recipient of the second Harrington Prize for Innovation in Medicine, announced Tuesday by the Harrington Discovery Institute at University Hospitals.
Dr. Douglas Lowy, chief of the Laboratory of Cellular Oncology and deputy director of the NCI, will receive a $20,000 honorarium for his nearly three decades of work in the field. Lowy and NCI colleague John Schiller, in collaboration with Merck and GlaxoSmithKline, developed the HPV vaccine, which was FDA-approved in 2006. It was the first vaccine to prevent cancer by warding off the viral infection that causes the disease."